NCT01189903 Clinical Evaluation - A Phase IIA Proof of Concept Study of Regorafenib (Bayer 73-4506) in Biopsy-amenable Asian Colorectal Cancer Patients Status UNKNOWN Phase PHASE2/PHASE3
NCT01068769 Regorafenib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor Status COMPLETED Phase PHASE2